Sanofi-Aventis, the French drug powerhouse that has one of its research sites in Cambridge, MA, has agreed to contribute $500,000 over the next two years to a state program that provides financing to life sciences startups in Massachusetts, according to the Massachusetts Life Sciences Center, which administers the program. The program is one of several components of the state’s $1 billion life sciences initiative, a 10-year plan launched in 2008 to spur growth in the life sciences industry with grants, tax incentives, and loans to researchers and companies in the commonwealth.
Author: Ryan McBride
Ryan is an award-winning business journalist who contributes to our life sciences and technology coverage. He was previously a staff writer for Mass High Tech, a Boston business and technology newspaper, where he and his colleagues won a national business journalism award from the Society of American Business Editors and Writers in 2008. In recent years, he has made regular TV appearances on New England Cable News.
Prior to MHT, Ryan covered the life sciences, technology, and energy sectors for Providence Business News. He graduated with honors from the University of Rhode Island in 2001 with a bachelor’s degree in communications. When he’s not chasing down news, Ryan enjoys mountain biking and skiing in his home state of Vermont.
View all posts by Ryan McBride
